Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997

The nonpeptide bradykinin (BK) B 2 receptor antagonist, FR165649 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐ methylcarbamoyl)cinnamidoacetyl] ‐N‐methylamino] benzyloxy] ‐2 ‐ methylquinoline), and agonist, FR190997 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐methylcarbamoyl) cinnamidoacetyl]‐N‐methylamino]benzyloxy]‐2‐meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2009-02, Vol.124 (3), p.441-446
Hauptverfasser: Asano, Masayuki, Hatori, Chie, Sawai, Hiroe, Johki, Shigeru, Inamura, Noriaki, Kayakiri, Hiroshi, Satoh, Shigeki, Abe, Yoshito, Inoue, Takayuki, Sawada, Yuki, Mizutani, Tsuyoshi, Oku, Teruo, Nakahara, Kunio
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 446
container_issue 3
container_start_page 441
container_title British journal of pharmacology
container_volume 124
creator Asano, Masayuki
Hatori, Chie
Sawai, Hiroe
Johki, Shigeru
Inamura, Noriaki
Kayakiri, Hiroshi
Satoh, Shigeki
Abe, Yoshito
Inoue, Takayuki
Sawada, Yuki
Mizutani, Tsuyoshi
Oku, Teruo
Nakahara, Kunio
description The nonpeptide bradykinin (BK) B 2 receptor antagonist, FR165649 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐ methylcarbamoyl)cinnamidoacetyl] ‐N‐methylamino] benzyloxy] ‐2 ‐ methylquinoline), and agonist, FR190997 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐methylcarbamoyl) cinnamidoacetyl]‐N‐methylamino]benzyloxy]‐2‐methyl‐4‐(2‐pyridylmethoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2‐pyridylmethoxy group is the only structural difference between them. Both FR165649 and FR190997 displaced [ 3 H]‐BK binding to B 2 receptors in guinea‐pig ileum membranes, with an IC 50 of 4.7×10 −10 M and 1.5×10 −9 M , respectively. They also displaced [ 3 H]‐BK binding to B 2 receptors in human lung fibroblast IMR‐90 cells, with an IC 50 of 1.6×10 −9 M and 9.8×10 −10 M , respectively. In guinea‐pig isolated ileum‐preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration‐response curves to BK on contraction. Analysis of the data produced a nominal pA 2 value of 9.2±0.1 ( n =5) and a slope of 1.4±0.1 ( n =5). On the other hand, FR190997 induced concentration‐dependent contraction of guinea‐pig ilea with a pD 2 of 7.9±0.2 and the contraction was inhibited by a specific peptide bradykinin B 2 receptor antagonist, Hoe 140 ( D ‐Arg‐[Hyp 3 , Thi 5 , D ‐Tic 7 , Oic 8 ]BK) in a non‐competitive manner. In IMR‐90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10 −7 M ) of the concentration‐response curves to BK on PI hydrolysis. FR190997 induced concentration‐dependent PI hydrolysis in IMR‐90 cells with a pD 2 of 8.4±0.1, and this effect was inhibited by Hoe 140. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B 2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.
doi_str_mv 10.1038/sj.bjp.0701813
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1038_sj_bjp_0701813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_sj_bjp_0701813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c169t-897b4d0f759b7d8de3bedf2ec538b024dc17915735b658b96cc2de00bcbc95e43</originalsourceid><addsrcrecordid>eNpNkE1LxDAYhIMouK5ePecHbOubpmmSoy5-wYIiei756pq6m5Qkl_XXW3EPnoaZgYF5ELomUBOg4iaPtR6nGjgQQegJWpCWdxWjgpyiBQDwihAhztFFziPAXHK2QOX1U6W9MnEXt96oHTazV6a45L9V8THgOGCFQwyTm4q3Duuk7OHLBx_wHW5wcmYuYsIqFLWNweeywg9vpGNdK1dzavH_WIKU_BKdDWqX3dVRl-jj4f59_VRtXh6f17ebypBOlkpIrlsLA2dScyuso9rZoXFm_qShaa0hXBLGKdMdE1p2xjTWAWijjWSupUtU_-2aFHNObuin5PcqHXoC_S-zPo_9zKw_MqM_NNZgbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997</title><source>Wiley Free Content</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Asano, Masayuki ; Hatori, Chie ; Sawai, Hiroe ; Johki, Shigeru ; Inamura, Noriaki ; Kayakiri, Hiroshi ; Satoh, Shigeki ; Abe, Yoshito ; Inoue, Takayuki ; Sawada, Yuki ; Mizutani, Tsuyoshi ; Oku, Teruo ; Nakahara, Kunio</creator><creatorcontrib>Asano, Masayuki ; Hatori, Chie ; Sawai, Hiroe ; Johki, Shigeru ; Inamura, Noriaki ; Kayakiri, Hiroshi ; Satoh, Shigeki ; Abe, Yoshito ; Inoue, Takayuki ; Sawada, Yuki ; Mizutani, Tsuyoshi ; Oku, Teruo ; Nakahara, Kunio</creatorcontrib><description>The nonpeptide bradykinin (BK) B 2 receptor antagonist, FR165649 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐ methylcarbamoyl)cinnamidoacetyl] ‐N‐methylamino] benzyloxy] ‐2 ‐ methylquinoline), and agonist, FR190997 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐methylcarbamoyl) cinnamidoacetyl]‐N‐methylamino]benzyloxy]‐2‐methyl‐4‐(2‐pyridylmethoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2‐pyridylmethoxy group is the only structural difference between them. Both FR165649 and FR190997 displaced [ 3 H]‐BK binding to B 2 receptors in guinea‐pig ileum membranes, with an IC 50 of 4.7×10 −10 M and 1.5×10 −9 M , respectively. They also displaced [ 3 H]‐BK binding to B 2 receptors in human lung fibroblast IMR‐90 cells, with an IC 50 of 1.6×10 −9 M and 9.8×10 −10 M , respectively. In guinea‐pig isolated ileum‐preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration‐response curves to BK on contraction. Analysis of the data produced a nominal pA 2 value of 9.2±0.1 ( n =5) and a slope of 1.4±0.1 ( n =5). On the other hand, FR190997 induced concentration‐dependent contraction of guinea‐pig ilea with a pD 2 of 7.9±0.2 and the contraction was inhibited by a specific peptide bradykinin B 2 receptor antagonist, Hoe 140 ( D ‐Arg‐[Hyp 3 , Thi 5 , D ‐Tic 7 , Oic 8 ]BK) in a non‐competitive manner. In IMR‐90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10 −7 M ) of the concentration‐response curves to BK on PI hydrolysis. FR190997 induced concentration‐dependent PI hydrolysis in IMR‐90 cells with a pD 2 of 8.4±0.1, and this effect was inhibited by Hoe 140. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B 2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0701813</identifier><language>eng</language><ispartof>British journal of pharmacology, 2009-02, Vol.124 (3), p.441-446</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c169t-897b4d0f759b7d8de3bedf2ec538b024dc17915735b658b96cc2de00bcbc95e43</citedby><cites>FETCH-LOGICAL-c169t-897b4d0f759b7d8de3bedf2ec538b024dc17915735b658b96cc2de00bcbc95e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Asano, Masayuki</creatorcontrib><creatorcontrib>Hatori, Chie</creatorcontrib><creatorcontrib>Sawai, Hiroe</creatorcontrib><creatorcontrib>Johki, Shigeru</creatorcontrib><creatorcontrib>Inamura, Noriaki</creatorcontrib><creatorcontrib>Kayakiri, Hiroshi</creatorcontrib><creatorcontrib>Satoh, Shigeki</creatorcontrib><creatorcontrib>Abe, Yoshito</creatorcontrib><creatorcontrib>Inoue, Takayuki</creatorcontrib><creatorcontrib>Sawada, Yuki</creatorcontrib><creatorcontrib>Mizutani, Tsuyoshi</creatorcontrib><creatorcontrib>Oku, Teruo</creatorcontrib><creatorcontrib>Nakahara, Kunio</creatorcontrib><title>Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997</title><title>British journal of pharmacology</title><description>The nonpeptide bradykinin (BK) B 2 receptor antagonist, FR165649 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐ methylcarbamoyl)cinnamidoacetyl] ‐N‐methylamino] benzyloxy] ‐2 ‐ methylquinoline), and agonist, FR190997 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐methylcarbamoyl) cinnamidoacetyl]‐N‐methylamino]benzyloxy]‐2‐methyl‐4‐(2‐pyridylmethoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2‐pyridylmethoxy group is the only structural difference between them. Both FR165649 and FR190997 displaced [ 3 H]‐BK binding to B 2 receptors in guinea‐pig ileum membranes, with an IC 50 of 4.7×10 −10 M and 1.5×10 −9 M , respectively. They also displaced [ 3 H]‐BK binding to B 2 receptors in human lung fibroblast IMR‐90 cells, with an IC 50 of 1.6×10 −9 M and 9.8×10 −10 M , respectively. In guinea‐pig isolated ileum‐preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration‐response curves to BK on contraction. Analysis of the data produced a nominal pA 2 value of 9.2±0.1 ( n =5) and a slope of 1.4±0.1 ( n =5). On the other hand, FR190997 induced concentration‐dependent contraction of guinea‐pig ilea with a pD 2 of 7.9±0.2 and the contraction was inhibited by a specific peptide bradykinin B 2 receptor antagonist, Hoe 140 ( D ‐Arg‐[Hyp 3 , Thi 5 , D ‐Tic 7 , Oic 8 ]BK) in a non‐competitive manner. In IMR‐90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10 −7 M ) of the concentration‐response curves to BK on PI hydrolysis. FR190997 induced concentration‐dependent PI hydrolysis in IMR‐90 cells with a pD 2 of 8.4±0.1, and this effect was inhibited by Hoe 140. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B 2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.</description><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpNkE1LxDAYhIMouK5ePecHbOubpmmSoy5-wYIiei756pq6m5Qkl_XXW3EPnoaZgYF5ELomUBOg4iaPtR6nGjgQQegJWpCWdxWjgpyiBQDwihAhztFFziPAXHK2QOX1U6W9MnEXt96oHTazV6a45L9V8THgOGCFQwyTm4q3Duuk7OHLBx_wHW5wcmYuYsIqFLWNweeywg9vpGNdK1dzavH_WIKU_BKdDWqX3dVRl-jj4f59_VRtXh6f17ebypBOlkpIrlsLA2dScyuso9rZoXFm_qShaa0hXBLGKdMdE1p2xjTWAWijjWSupUtU_-2aFHNObuin5PcqHXoC_S-zPo_9zKw_MqM_NNZgbA</recordid><startdate>20090203</startdate><enddate>20090203</enddate><creator>Asano, Masayuki</creator><creator>Hatori, Chie</creator><creator>Sawai, Hiroe</creator><creator>Johki, Shigeru</creator><creator>Inamura, Noriaki</creator><creator>Kayakiri, Hiroshi</creator><creator>Satoh, Shigeki</creator><creator>Abe, Yoshito</creator><creator>Inoue, Takayuki</creator><creator>Sawada, Yuki</creator><creator>Mizutani, Tsuyoshi</creator><creator>Oku, Teruo</creator><creator>Nakahara, Kunio</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090203</creationdate><title>Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997</title><author>Asano, Masayuki ; Hatori, Chie ; Sawai, Hiroe ; Johki, Shigeru ; Inamura, Noriaki ; Kayakiri, Hiroshi ; Satoh, Shigeki ; Abe, Yoshito ; Inoue, Takayuki ; Sawada, Yuki ; Mizutani, Tsuyoshi ; Oku, Teruo ; Nakahara, Kunio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c169t-897b4d0f759b7d8de3bedf2ec538b024dc17915735b658b96cc2de00bcbc95e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asano, Masayuki</creatorcontrib><creatorcontrib>Hatori, Chie</creatorcontrib><creatorcontrib>Sawai, Hiroe</creatorcontrib><creatorcontrib>Johki, Shigeru</creatorcontrib><creatorcontrib>Inamura, Noriaki</creatorcontrib><creatorcontrib>Kayakiri, Hiroshi</creatorcontrib><creatorcontrib>Satoh, Shigeki</creatorcontrib><creatorcontrib>Abe, Yoshito</creatorcontrib><creatorcontrib>Inoue, Takayuki</creatorcontrib><creatorcontrib>Sawada, Yuki</creatorcontrib><creatorcontrib>Mizutani, Tsuyoshi</creatorcontrib><creatorcontrib>Oku, Teruo</creatorcontrib><creatorcontrib>Nakahara, Kunio</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asano, Masayuki</au><au>Hatori, Chie</au><au>Sawai, Hiroe</au><au>Johki, Shigeru</au><au>Inamura, Noriaki</au><au>Kayakiri, Hiroshi</au><au>Satoh, Shigeki</au><au>Abe, Yoshito</au><au>Inoue, Takayuki</au><au>Sawada, Yuki</au><au>Mizutani, Tsuyoshi</au><au>Oku, Teruo</au><au>Nakahara, Kunio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997</atitle><jtitle>British journal of pharmacology</jtitle><date>2009-02-03</date><risdate>2009</risdate><volume>124</volume><issue>3</issue><spage>441</spage><epage>446</epage><pages>441-446</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>The nonpeptide bradykinin (BK) B 2 receptor antagonist, FR165649 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐ methylcarbamoyl)cinnamidoacetyl] ‐N‐methylamino] benzyloxy] ‐2 ‐ methylquinoline), and agonist, FR190997 (8‐[2,6‐dichloro‐3‐[N‐[(E)‐4‐(N‐methylcarbamoyl) cinnamidoacetyl]‐N‐methylamino]benzyloxy]‐2‐methyl‐4‐(2‐pyridylmethoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2‐pyridylmethoxy group is the only structural difference between them. Both FR165649 and FR190997 displaced [ 3 H]‐BK binding to B 2 receptors in guinea‐pig ileum membranes, with an IC 50 of 4.7×10 −10 M and 1.5×10 −9 M , respectively. They also displaced [ 3 H]‐BK binding to B 2 receptors in human lung fibroblast IMR‐90 cells, with an IC 50 of 1.6×10 −9 M and 9.8×10 −10 M , respectively. In guinea‐pig isolated ileum‐preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration‐response curves to BK on contraction. Analysis of the data produced a nominal pA 2 value of 9.2±0.1 ( n =5) and a slope of 1.4±0.1 ( n =5). On the other hand, FR190997 induced concentration‐dependent contraction of guinea‐pig ilea with a pD 2 of 7.9±0.2 and the contraction was inhibited by a specific peptide bradykinin B 2 receptor antagonist, Hoe 140 ( D ‐Arg‐[Hyp 3 , Thi 5 , D ‐Tic 7 , Oic 8 ]BK) in a non‐competitive manner. In IMR‐90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10 −7 M ) of the concentration‐response curves to BK on PI hydrolysis. FR190997 induced concentration‐dependent PI hydrolysis in IMR‐90 cells with a pD 2 of 8.4±0.1, and this effect was inhibited by Hoe 140. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B 2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.</abstract><doi>10.1038/sj.bjp.0701813</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2009-02, Vol.124 (3), p.441-446
issn 0007-1188
1476-5381
language eng
recordid cdi_crossref_primary_10_1038_sj_bjp_0701813
source Wiley Free Content; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
title Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T16%3A17%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20characterization%20of%20a%20nonpeptide%20bradykinin%20B%202%20receptor%20antagonist,%20FR165649,%20and%20agonist,%20FR190997&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Asano,%20Masayuki&rft.date=2009-02-03&rft.volume=124&rft.issue=3&rft.spage=441&rft.epage=446&rft.pages=441-446&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0701813&rft_dat=%3Ccrossref%3E10_1038_sj_bjp_0701813%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true